Incyte (INCY) Change in Account Payables (2010 - 2026)
Incyte (INCY) posted Change in Account Payables of $23.4 million for Q1 2026, down 28.89% on a QoQ basis from $33.0 million in Q4 2025, and up 1186.1% year-over-year from $1.8 million in Q1 2025.
Incyte (INCY) Change in Account Payables (2010 - 2026) Analysis & Trends
Incyte's Change in Account Payables history runs 17 years deep, the most recent figure standing at $23.4 million for Q1 2026.
- Quarterly Change in Account Payables rose 1186.1% year-over-year to $23.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.2 million (up 2.57% YoY) and the FY2025 annual result came in at $6.6 million, down 92.56% from the prior year.
- Change in Account Payables was $23.4 million for Q1 2026 at Incyte, down from $33.0 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $114.4 million in Q4 2022 and bottomed at -$221.9 million in Q1 2023.
- A 5-year average of $3.3 million and a median of $19.0 million in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables plunged 1034.35% — and 2026, when it soared 1186.1%.
- Incyte's Change in Account Payables stood at $114.4 million in 2022, then slumped by 126.06% to -$29.8 million in 2023, then surged by 163.9% to $19.0 million in 2024, then surged by 73.1% to $33.0 million in 2025, then decreased by 28.89% to $23.4 million in 2026.
- Business Quant data shows INCY's Change in Account Payables at $23.4 million in Q1 2026, $33.0 million in Q4 2025, and -$44.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | 23.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.45 Mn |
| Mar 31, 2026 | 23.45 Mn |
| Dec 31, 2025 | 32.98 Mn |
| Dec 31, 2025 | 32.98 Mn |
| Sep 30, 2025 | -44.17 Mn |
| Sep 30, 2025 | -44.17 Mn |
| Jun 30, 2025 | 19.91 Mn |
| Jun 30, 2025 | 19.91 Mn |
| Mar 31, 2025 | -2.16 Mn |
| Mar 31, 2025 | -2.16 Mn |
| Dec 31, 2024 | 19.05 Mn |
| Dec 31, 2024 | 19.05 Mn |
| Sep 30, 2024 | 30.54 Mn |
| Sep 30, 2024 | 30.54 Mn |
| Jun 30, 2024 | -16.06 Mn |
| Jun 30, 2024 | -16.06 Mn |
| Mar 31, 2024 | 54.64 Mn |
| Mar 31, 2024 | 54.64 Mn |
| Dec 31, 2023 | -29.81 Mn |
| Dec 31, 2023 | -29.81 Mn |